Finance

Beta
Lists
IDYA:NASDAQ
Ideaya Biosciences Inc
$36.74
+1.24%
(+0.45) 1D
$36.74
+0.00% (+0.00070)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IDYA...
Open
$36.60
High
$37.02
Low
$36.02
Mkt. cap
3.49B
Avg. vol.
1.20M
Volume
3.68M
52-wk high
$39.28
52-wk low
$20.50
EPS
-$1.60
Beta
-0.04
Shares outstanding
93.42M
No. of employees
145
Open
$36.60
High
$37.02
Low
$36.02
Mkt. cap
3.49B
Avg. vol.
1.20M
Volume
3.68M
52-wk high
$39.28
52-wk low
$20.50
EPS
-$1.60
Beta
-0.04
Shares outstanding
93.42M
No. of employees
145
News stories
From sources across the web
About Ideaya Biosciences Inc
CEO-
Employees145
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websiteideayabio.com
Analyst ratings
Based on 13 analysts giving stock ratings to IDYA in the past 3 months
Strong buy
Buy
12
Hold
1
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for IDYA in the last 3 months.
Highest
Current $36.74
$66.00 (+79.64%)
Average
$54.00 (+46.98%)
Lowest
$36.00 (-2.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$50.00
+36.1%
06/16/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$62.00
+68.8%
06/15/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$58.00
+57.9%
06/12/2026
Michael Yee
UBS
Buy
Reiterated
$50.00
+36.1%
06/09/2026
Corinne Johnson
Goldman Sachs
Hold
Maintained
$36.00
-2%
06/03/2026
Gregory Renza
Truist Financial
Buy
Reiterated
-
-
06/02/2026
Paul Jeng
Guggenheim
Buy
Maintained
$54.00
+47%
06/02/2026
Anupam Rama
J.P. Morgan
Buy
Maintained
$66.00
+79.6%
05/29/2026
Leonid Timashev
RBC Capital
Buy
Maintained
$53.00
+44.3%
05/05/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/05/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
$48.00
+30.6%
04/14/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$65.00
+76.9%
04/13/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
$35.00
-4.7%
04/14/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$48.00
+30.6%
04/14/2026
Maury Raycroft
Jefferies
Buy
Maintained
$52.00
+41.5%
04/05/2026
Last report
May 5, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.11 / -$0.98
-13.46%miss
Revenue / Est. (USD)
6.56M / 5.04M
+30.20%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
207.83M
10.88M
6.56M
Cost of goods sold
74.23M
82.99M
86.60M
95.73M
Cost of revenue
74.23M
82.99M
86.60M
95.73M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.58M
16.39M
18.85M
19.38M
Operating expense
14.58M
16.39M
18.85M
19.38M
Total operating expenses
88.81M
99.38M
105.45M
115.10M
Operating income
-88.81M
108.45M
-94.57M
-108.54M
Other non operating income
-
-
-
-
EBT including unusual items
-77.49M
119.24M
-83.27M
-98.54M
EBT excluding unusual items
-77.49M
119.24M
-93.25M
-98.54M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-77.49M
119.24M
-83.27M
-98.54M
Net profit margin
-
57.37%
-765.66%
-1,502.12%
Earnings per share
-0.88
1.33
-0.94
-1.11
Interest and investment income
11.32M
10.79M
1.32M
10.00M
Interest expense
-
-
-
-
Net interest expenses
11.32M
10.79M
1.32M
10.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-88.09M
109.11M
-93.85M
-107.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of IDYA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer